REFERENCES 1. van der Kooi TI, Mannien J, Wille JC, van Benthem BH. Prevalence of nosocomial infections in The Netherlands, 2007‐2008: results of the first four national studies. J Hosp Infect 2010; 75: 168‐172. doi:10.1016/j.jhin.2009.11.020 . 2. L'Heriteau F, Olivier M, Maugat S et al. Impact of a five‐year surveillance of central venous catheter infections in the REACAT intensive care unit network in France. J Hosp Infect 2007; 66: 123‐129. doi:10.1016/j.jhin.2007.03.014. 3. Garnacho‐Montero J, Aldabo‐Pallas T, Palomar‐Martinez M et al. Risk factors and prognosis of catheter‐related bloodstream infection in critically ill patients: a multicenter study. Intensive Care Med 2008; 34: 2185‐2193. DOI 10.1007/s00134‐008‐1204‐7. 4. Gastmeier P, Geffers C, Brandt C et al. Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections. J Hosp Infect 2006; 64: 16‐22. doi:10.1016/j.jhin.2006.04.017. 5. Templeton A, Schlegel M, Fleisch F et al. Multilumen central venous catheters increase risk for catheter‐related bloodstream infection: prospective surveillance study. Infection 2008; 36: 322‐327. 6. Agodi A, Auxilia F, Barchitta M et al. Building a benchmark through active surveillance of intensive care unit‐acquired infections: the Italian network SPIN‐UTI. J Hosp Infect 2010; 74: 258‐65. doi:10.1016/j.jhin.2009.08.015. 7. Blot SI, Depuydt P, Annemans L et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter‐related bloodstream infections. Clin Infect Dis 2005; 41: 1591‐1598. doi:10.1053/jhin.2002.1329. 8. Higuera F, Rangel‐Frausto MS, Rosenthal VD et al. Attributable cost and length of stay for patients with central venous catheter‐associated bloodstream infection in Mexico City intensive care units: a prospective, matched analysis. Infect Control Hosp Epidemiol 2007; 28: 31‐35. DOI: 10.1097/01.CCM.0000178190.89663.E5 . 9. Tacconelli E, Smith G, Hieke K, Lafuma A, Bastide P. Epidemiology, medical outcomes and costs of catheter‐related bloodstream infections in intensive care units of four European countries: literature‐ and registry‐based estimates. J Hosp Infect 2009; 72: 97‐103. doi:10.1016/j.jhin.2008.12.012. 10. Hollander AEM, Hoeymans N, Melse JM, Oers JAMv, Polder JJ. Zorg voor Gezondheid . Volksgezondheid Toekomst Verkenning 2006 (Care for Health. Exploration of the Future of Public Health 2006). Bilthoven: National Institute of Public Health and the Environment (RIVM), 2006. 11. Harbarth S, Sax H, Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect 2003; 54: 258‐266. doi:10.1016/S0195‐6701(03)00150‐6. 12. Gastmeier P, Geffers C. Prevention of catheter‐related bloodstream infections: analysis of studies published between 2002 and 2005. J Hosp Infect 2006; 64: 326‐335. doi:10.1016/j.jhin.2006.07.005. 13. Al Raiy B, Fakih MG, Bryan‐Nomides N et al. Peripherally inserted central venous catheters in the acute care setting: A safe alternative to high‐risk short‐term central venous catheters. Am J Infect Control 2010; 38: 149‐153. 14. Casey AL, Mermel LA, Nightingale P, Elliott TS. Antimicrobial central venous catheters in adults: a systematic review and meta‐analysis. Lancet Infect Dis 2008; 8: 763‐776. 15. Esteve F, Pujol M, Limon E et al. Bloodstream infection related to catheter connections: a prospective trial of two connection systems. J Hosp Infect 2007; 67: 30‐34. doi:10.1016/j.jhin.2007.05.021. 16. Schuerer DJ, Zack JE, Thomas J et al. Effect of chlorhexidine/silver sulfadiazine‐impregnated central 54 Chapter 3
RkJQdWJsaXNoZXIy MTk4NDMw